Journal article
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study
Abstract
BackgroundOlder patients are prone to multimorbidity and polypharmacy, with an inherent risk of adverse events and drug interactions. To the best of our knowledge, available information on the appropriateness of lipid-lowering treatment is extremely limited.AimThe aim of the present study was to quantify and characterize lipid-lowering drug use in a population of complex in-hospital older patients.MethodsWe analyzed data from 87 units of …
Authors
Bertolotti M; Franchi C; Rocchi MBL; Miceli A; Libbra MV; Nobili A; Lancellotti G; Carulli L; Mussi C; On behalf of REPOSI Investigators
Journal
Drugs & Aging, Vol. 34, No. 4, pp. 311–319
Publisher
Springer Nature
Publication Date
4 2017
DOI
10.1007/s40266-017-0448-8
ISSN
1170-229X